Clopidogrel is an oral, thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. CPG Clopidrogel reduces the risk of heart attacks and strokes (which usually are caused by blood clots) increase in patients with a recent history of stroke or heart attack, and patients with peripheral vascular disease. CPG Clopidrogel film-coated tablets come in a 2x10 blister pack and each film-coated tablet contains:
Clopidrogel bisulfate 97.9mg equivalent to Clopidrogel base 75mg.
CPG ® is indicated for the following
CPG ® indications include:.
CPG Clopidrogel is recommended by ACC/AHA & ESC Guidelines